Compositions and methods for treating articular cartilage disorders

A method for treating mammalian articular cartilage disorders, more particularly osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeuti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PIKE MARILYN C, OWEN RALPH M, WOLFGANG GRUSHENKA H. I, SEELY LYNN B, GULER HANS-PETER, CHEN SHARON A
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PIKE MARILYN C
OWEN RALPH M
WOLFGANG GRUSHENKA H. I
SEELY LYNN B
GULER HANS-PETER
CHEN SHARON A
description A method for treating mammalian articular cartilage disorders, more particularly osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level that is capable of maintenance and/or regeneration of cartilage, which is beneficial to the long-term treatment of osteoarthritis and trauma-related injuries to cartilage tissues. In one embodiment of the invention, single doses of at least 0.01 mg of pharmaceutically effective IGF-I are administered intermittently such that the duration of time off of therapy is greater than the time on therapy, more preferably with a frequency of administration of about once per week or less.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7141545B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7141545B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7141545B23</originalsourceid><addsrcrecordid>eNqNyjEOwjAMQNEsDAi4gy_AUGjFTgRiB-bKStxiKY0j29wfIXEApv-Gvw4xytLE2FmqAdYMC_lLssEkCq6EznUGVOf0LqiQviw4E2Q20Uxq27CasBjtft0EuF4e8banJiNZw0SVfHzeT13fDf1wPhz_WD5wETLn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Compositions and methods for treating articular cartilage disorders</title><source>esp@cenet</source><creator>PIKE MARILYN C ; OWEN RALPH M ; WOLFGANG GRUSHENKA H. I ; SEELY LYNN B ; GULER HANS-PETER ; CHEN SHARON A</creator><creatorcontrib>PIKE MARILYN C ; OWEN RALPH M ; WOLFGANG GRUSHENKA H. I ; SEELY LYNN B ; GULER HANS-PETER ; CHEN SHARON A</creatorcontrib><description>A method for treating mammalian articular cartilage disorders, more particularly osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level that is capable of maintenance and/or regeneration of cartilage, which is beneficial to the long-term treatment of osteoarthritis and trauma-related injuries to cartilage tissues. In one embodiment of the invention, single doses of at least 0.01 mg of pharmaceutically effective IGF-I are administered intermittently such that the duration of time off of therapy is greater than the time on therapy, more preferably with a frequency of administration of about once per week or less.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061128&amp;DB=EPODOC&amp;CC=US&amp;NR=7141545B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061128&amp;DB=EPODOC&amp;CC=US&amp;NR=7141545B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PIKE MARILYN C</creatorcontrib><creatorcontrib>OWEN RALPH M</creatorcontrib><creatorcontrib>WOLFGANG GRUSHENKA H. I</creatorcontrib><creatorcontrib>SEELY LYNN B</creatorcontrib><creatorcontrib>GULER HANS-PETER</creatorcontrib><creatorcontrib>CHEN SHARON A</creatorcontrib><title>Compositions and methods for treating articular cartilage disorders</title><description>A method for treating mammalian articular cartilage disorders, more particularly osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level that is capable of maintenance and/or regeneration of cartilage, which is beneficial to the long-term treatment of osteoarthritis and trauma-related injuries to cartilage tissues. In one embodiment of the invention, single doses of at least 0.01 mg of pharmaceutically effective IGF-I are administered intermittently such that the duration of time off of therapy is greater than the time on therapy, more preferably with a frequency of administration of about once per week or less.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEOwjAMQNEsDAi4gy_AUGjFTgRiB-bKStxiKY0j29wfIXEApv-Gvw4xytLE2FmqAdYMC_lLssEkCq6EznUGVOf0LqiQviw4E2Q20Uxq27CasBjtft0EuF4e8banJiNZw0SVfHzeT13fDf1wPhz_WD5wETLn</recordid><startdate>20061128</startdate><enddate>20061128</enddate><creator>PIKE MARILYN C</creator><creator>OWEN RALPH M</creator><creator>WOLFGANG GRUSHENKA H. I</creator><creator>SEELY LYNN B</creator><creator>GULER HANS-PETER</creator><creator>CHEN SHARON A</creator><scope>EVB</scope></search><sort><creationdate>20061128</creationdate><title>Compositions and methods for treating articular cartilage disorders</title><author>PIKE MARILYN C ; OWEN RALPH M ; WOLFGANG GRUSHENKA H. I ; SEELY LYNN B ; GULER HANS-PETER ; CHEN SHARON A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7141545B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PIKE MARILYN C</creatorcontrib><creatorcontrib>OWEN RALPH M</creatorcontrib><creatorcontrib>WOLFGANG GRUSHENKA H. I</creatorcontrib><creatorcontrib>SEELY LYNN B</creatorcontrib><creatorcontrib>GULER HANS-PETER</creatorcontrib><creatorcontrib>CHEN SHARON A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PIKE MARILYN C</au><au>OWEN RALPH M</au><au>WOLFGANG GRUSHENKA H. I</au><au>SEELY LYNN B</au><au>GULER HANS-PETER</au><au>CHEN SHARON A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Compositions and methods for treating articular cartilage disorders</title><date>2006-11-28</date><risdate>2006</risdate><abstract>A method for treating mammalian articular cartilage disorders, more particularly osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level that is capable of maintenance and/or regeneration of cartilage, which is beneficial to the long-term treatment of osteoarthritis and trauma-related injuries to cartilage tissues. In one embodiment of the invention, single doses of at least 0.01 mg of pharmaceutically effective IGF-I are administered intermittently such that the duration of time off of therapy is greater than the time on therapy, more preferably with a frequency of administration of about once per week or less.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US7141545B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Compositions and methods for treating articular cartilage disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A23%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PIKE%20MARILYN%20C&rft.date=2006-11-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7141545B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true